Investigation of clinical usefulness of serum biomarker for patients with IBD. And analyse correlations between efficacy of GMA and serum biomarker.

Not Applicable

• Conditions: lcerative colitis Crohn' s disease

• Registration Number: JPRN-UMIN000019864
• Lead Sponsor: Juntendo University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-04
• Study Completion: 2017-10-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Not provided

Exclusion Criteria

1:Patient with granulocytopenia (granulocyte count < 2,000/mm3). 2:Patient with or suspected to have severe infection. 3:Patient who judged to be exclusive by investigators for a certain reason.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical response rate. UC:Mayo score >= 30% decrease partial Mayo score >= 30% decrease CD:CDAI score >= 70 decrease

Secondary Outcome Measures

Name	Time	Method
Clinical response rate. UC:Mayo score <= 2 partial Mayo score<= 2 CD:CDAI score<= 150